AtriCure Files 8-K/A Amendment
Ticker: ATRC · Form: 8-K/A · Filed: Oct 29, 2025 · CIK: 1323885
Sentiment: neutral
Topics: amendment, financial-reporting
TL;DR
AtriCure filed an 8-K/A amendment on Oct 29, 2025, updating financial info.
AI Summary
AtriCure, Inc. filed an 8-K/A amendment on October 29, 2025, to report results of operations and financial condition, as well as financial statements and exhibits. This filing amends a previous report and provides updated information regarding the company's financial performance and related disclosures.
Why It Matters
This amendment provides updated financial information and disclosures for AtriCure, Inc., which is crucial for investors to assess the company's current financial health and performance.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and primarily concerns financial disclosures, not a new event that inherently increases risk.
Key Players & Entities
- AtriCure, Inc. (company) — Registrant
- October 29, 2025 (date) — Date of Report
- 7555 Innovation Way, Mason OH 45040 (address) — Principal Executive Offices
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previous report, intended to update information regarding AtriCure, Inc.'s results of operations and financial condition, as well as financial statements and exhibits.
When was this amendment filed?
This amendment was filed on October 29, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 7555 Innovation Way, Mason, OH 45040.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 34-1940305.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 635 words · 3 min read · ~2 pages · Grade level 9.5 · Accepted 2025-10-29 17:18:33
Filing Documents
- atrc-20251029.htm (8-K/A) — 28KB
- exhibit991-10292025xamendm.htm (EX-99.1) — 146KB
- image_0.jpg (GRAPHIC) — 3KB
- 0001323885-25-000101.txt ( ) — 307KB
- atrc-20251029.xsd (EX-101.SCH) — 2KB
- atrc-20251029_lab.xml (EX-101.LAB) — 22KB
- atrc-20251029_pre.xml (EX-101.PRE) — 13KB
- atrc-20251029_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 29, 2025 , AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2025. The Company will hold a conference call on October 29, 2025 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in Item 2.02 of Form 8-K and in the press release attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in each of Item 2.02 of this Form 8-K and Exhibit 99.1 shall not be incorporated by reference in any filing or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing or document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 99.1 Press Release dated October 29, 2025, relating to financial results for the third quarter ended September 30, 2025. 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATRICURE, INC. Dated: October 29, 2025 By: /s/ Angela L. Wirick Angela L. Wirick Chief Financial Officer